[go: up one dir, main page]

CA2093361A1 - Derive porphyrine - Google Patents

Derive porphyrine

Info

Publication number
CA2093361A1
CA2093361A1 CA002093361A CA2093361A CA2093361A1 CA 2093361 A1 CA2093361 A1 CA 2093361A1 CA 002093361 A CA002093361 A CA 002093361A CA 2093361 A CA2093361 A CA 2093361A CA 2093361 A1 CA2093361 A1 CA 2093361A1
Authority
CA
Canada
Prior art keywords
bonds
amide
porphyrin derivative
rivatives
photosensitizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002093361A
Other languages
English (en)
Other versions
CA2093361C (fr
Inventor
Michel Ringuet
Roy H. Pottier
James C. Kennedy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queens University at Kingston
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2093361A1 publication Critical patent/CA2093361A1/fr
Application granted granted Critical
Publication of CA2093361C publication Critical patent/CA2093361C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002093361A 1990-10-05 1991-10-01 Derive porphyrine Expired - Fee Related CA2093361C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59386790A 1990-10-05 1990-10-05
US593,867 1990-10-05
PCT/CA1991/000346 WO1992006097A1 (fr) 1990-10-05 1991-10-01 Derives de prophyrine

Publications (2)

Publication Number Publication Date
CA2093361A1 true CA2093361A1 (fr) 1992-04-06
CA2093361C CA2093361C (fr) 2002-04-23

Family

ID=24376530

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002093361A Expired - Fee Related CA2093361C (fr) 1990-10-05 1991-10-01 Derive porphyrine

Country Status (6)

Country Link
EP (1) EP0553116A1 (fr)
AU (1) AU655942B2 (fr)
CA (1) CA2093361C (fr)
MX (1) MX9101448A (fr)
NZ (1) NZ240057A (fr)
WO (1) WO1992006097A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599924A (en) * 1992-08-14 1997-02-04 Trustees Of The University Of Pennsylvania Electron-deficient porphyrins and processes and intermediates for preparing same
US5817830A (en) * 1992-08-14 1998-10-06 Trustees Of The University Of Pennsylvania Pyrrolic compounds
US5371199B1 (en) * 1992-08-14 1995-12-26 Univ Pennsylvania Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor
US5493017A (en) * 1992-08-14 1996-02-20 The Trustees Of The University Of Pennsylvania Ring-metalated porphyrins
CA2189967A1 (fr) * 1994-05-11 1995-11-23 Guy Jacques Felix Marchal Utilisation de composes a base d'un complexe de porphyrine ou d'un complexe de porphyrine etendue comme preparation diagnostique pour la localisation d'un infarctus
US6013241A (en) * 1995-01-23 2000-01-11 Schering Aktiengesellschaft Use of porphyrin-complex or expanded porphyrin-complex compounds as an infarction localization diagnosticum
US6492420B2 (en) 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
CZ291132B6 (cs) * 1995-03-10 2002-12-11 Photocure Asa Estery kyselin 5-aminolevulových a farmaceutický prostředek s jejich obsahem
US7530461B2 (en) 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
US6838248B2 (en) 2000-11-17 2005-01-04 Biomoda, Inc. Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
EP1401430A4 (fr) 2001-05-31 2005-10-19 Miravant Pharm Inc Derives porphyrine et azaporphyrine substitues et utilisation en therapie photodynamique, radioimagerie, et diagnostic par irm
EP2596348B1 (fr) 2009-07-17 2017-09-06 bioAffinity Technologies, Inc. Système et procédé d analyse d échantillons marqués au moyen de la 5, 10, 15, 20 tétrakis (4-carboxyphényle) porphine (tcpp)
WO2017218959A1 (fr) 2016-06-16 2017-12-21 Oncoselect Therapeutics, Llc Composés de porphyrine et compositions utiles pour le traitement du cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
WO1986001720A1 (fr) * 1984-09-13 1986-03-27 Cytogen Corporation Conjugues d'agents therapeutiques-anticorps
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4886484A (en) * 1989-06-02 1989-12-12 Litens Automotive Partnership Torsional spring tensioner with stabilizer

Also Published As

Publication number Publication date
EP0553116A1 (fr) 1993-08-04
AU8612291A (en) 1992-04-28
NZ240057A (en) 1994-07-26
CA2093361C (fr) 2002-04-23
MX9101448A (es) 1992-06-05
WO1992006097A1 (fr) 1992-04-16
AU655942B2 (en) 1995-01-19

Similar Documents

Publication Publication Date Title
CA2093361A1 (fr) Derive porphyrine
ZA951292B (en) 4-amino derivatives of mycophenolic acid
CA2041260A1 (fr) Agents de contraste ultrasonore, leur procede de preparation et leur utilisation en tant qu'agents de diagnostic et de traitement
MY130110A (en) 6-substituted mycophenolic acid and derivatives
CA2406650A1 (fr) Agents de diagnostic cationique, d'imagerie et de therapie associes a des sites vasculaires actives
FR2729845B1 (fr) Catheter d'imagerie echographique endocavitaire
IT9067127A0 (it) Anello di sutura per protesi valvolari cardiache
FR2786770B1 (fr) Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
CA2145505A1 (fr) Preparation de microparticules a partir de copolymeres biodegradables
CY2436B1 (en) Medicament for treating cardiac inflammatory disease.
ATE261736T1 (de) Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen
FR2756563B1 (fr) Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
NZ234173A (en) Alpha-melanocyte stimulating hormone derivative (alphamsh)-targetted moiety conjugate
AU3861989A (en) Method for the treatment and the diagnosis of coronary heart disease
FI965094L (fi) 2,4,6-trijodi-5-substituoituja aminoisoftalaattiestereitä, jotka ovat hyödyllisiä varjoaineina lääketieteellisessä diagnostisessa kuvauksessa
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
CA2283450A1 (fr) Procedes de traitement de tissu cicatriciel
BR9506838A (pt) Derivados de ácido micofenólico substituídos na posição 5
CA2194294A1 (fr) Complexes destines au diagnostic de maladies vasculaires
IT1228402B (it) Posto letto per una cabina di guida di un autocarro.
FR2722501B1 (fr) Derives de 9h-imidazo(1,2-a)benzimidazole-3-acetamide, leur preparation et leur application en therapeutique
RU97102946A (ru) Способ диагностики острого гематогенного остеомиелита
FR2751970B1 (fr) Derives d'acide 6,7,8,9-tetrahydro-5h-imidazo[1,2-a]azepine- 3-acetique, leur preparation et leur application en therapeutique
AUPN352795A0 (en) Therapeutic agents for coronary heart disease
RU95122486A (ru) Средство для лечения тикозных гиперкинезов

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed